ACELYRIN
SLRN
SLRN was delisted on the 21st of May, 2025.
0 hedge funds and large institutions have $0 invested in ACELYRIN in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $704 → $0 (-$704)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$697 |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$7 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| – | -$697 | -282 | Closed |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| – | -$7 | -3 | Closed |
|
SLRN Hedge Fund Activity: Q3 2025 in Review
0 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q3 2025, worth a combined $0 — down 100% from $704 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SLRN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $697 sold.
- 0 institutional investors held ACELYRIN (SLRN) as of Q3 2025, down from 2 in Q2 2025.
- Funds reported $0 of ACELYRIN stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new ACELYRIN positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest ACELYRIN seller in Q3 2025 was Osaic Holdings, an estimated $697 sold.
Based on aggregated 13F filings for Q3 2025.